Navigation Links
Omeros Corporation Reports Second Quarter 2012 Financial Results
Date:8/7/2012

SEATTLE, Aug. 7, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2012.

Financial ResultsTotal operating expenses for the quarter ended June 30, 2012 were $9.8 million compared to $6.1 million for the same period in 2011. The increase in operating expenses primarily relates to increased Phase 3 clinical trial expenses for OMS302 and OMS103HP and an increase in expenses in connection with preclinical work for Omeros' PDE10 and MASP-2 programs in preparation for their advancement into the clinic. For the quarter ended June 30, 2012, Omeros reported a net loss of $8.5 million, or $0.38 per share, compared to a net loss of $5.3 million, or $0.24 per share, for the same period in 2011.

At June 30, 2012, Omeros had cash, cash equivalents and short-term investments of $7.3 million. On July 2, 2012, Omeros completed a public offering pursuant to which it sold 3,365,854 shares of its common stock at a price of $10.25 per share for estimated net proceeds of $32.4 million. 

"Our two ongoing Phase 3 clinical trials continued to advance during the quarter – OMS302 for lens replacement procedures and OMS103HP for arthroscopic meniscectomy surgery – and we expect to report data for both in the second half of this year," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.  "We have also begun to prepare the NDA for OMS302 which, assuming positive data from the ongoing clinical trial, we expect to submit to the FDA during the first part of 2013.  Our other programs also progressed, and we plan to file an IND for our PDE10 inhibitor this quarter with an IND f
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces Discovery in MASP-2 Program
2. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
3. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
4. Omeros Prices $30 Million Public Offering of Common Stock
5. Omeros Announces Proposed Public Offering of Common Stock
6. Omeros to Present at Jefferies 2012 Global Healthcare Conference
7. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
8. Omeros to Present at Deutsche Bank Securities Health Care Conference
9. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
10. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
11. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ... today that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") ... 2014. The terms of the acquisition were not disclosed. ... ("DME") company providing a wide range of sleep, mobility, and ... and Pittsburgh markets. Progressive ...
(Date:1/14/2014)... Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ... for oxygen when air is thin," states Dr Barnes. She goes ...
(Date:1/14/2014)... NineSigma , Inc., the leading innovation partner to ... , May 14-16, 2014 at the Global Center for ... This is the premier industry event ... through open innovation. Participants will learn how world-changing innovation ... even across industries. NineSigma clients, thought ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... May 3 US Oncology, Inc ., ... flexible offerings that can be customized to the needs ... expanded offerings, physicians can join more than a thousand ... to work together to realign reimbursement based on ...
... use in infants , , , ... May 3 Recently, researchers have observed a disturbing trend in ... name, metoclopramide -- to treat premature infants. This alarming development has raised serious concerns ... in infants. , , , ...
Cached Medicine Technology:US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 2US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 3US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 4Spike in Use of Popular Reflux Drug to Treat Infants Causes Alarm 2
(Date:3/7/2014)... Columbia University Medical Center (CUMC) researchers have found ... onset of a decision by a mere fraction of ... neuropsychiatric conditions characterized by abnormalities in cognitive function and ... high-stake environments. The study was published in the March ... . , "Decision making isn,t always easy, ...
(Date:3/7/2014)... March 7, 2014 -- Five researchers seeking to understand ... identifying women at risk of preterm labor and developing ... support from the March of Dimes. , The researchers, ... understand what role genetic variations, infection, fetal lung development ... labor. They have been awarded 2014 March of Dimes ...
(Date:3/7/2014)... study found more than 80 percent of raw chicken ... staff was contaminated with a form of antibiotic resistant ... . While sufficient preparation eliminated the presence of bacteria, ... point of entry for these dangerous bacteria into the ... of Infection Control and Hospital Epidemiology , the ...
(Date:3/7/2014)... The UK needs to invest in testing for those ... follow a cast-the-net-wide approach targeting the whole population, a ... of Manchester Cancer Research Centre - has argued at ... UK are currently entitled to PSA blood test for ... and will be recommended to have a prostate biopsy ...
(Date:3/6/2014)... UNC,s Frank Porter Graham Child Development Institute ... produces significant positive outcomes for children, regardless ... skills. FPG,s research on nearly 1,200 children ... and general knowledge for students enrolled in ... findings demonstrate compelling evidence for the impact ...
Breaking Medicine News(10 mins):Health News:Ever-so-slight delay improves decision-making accuracy 2Health News:Ever-so-slight delay improves decision-making accuracy 3Health News:New research seeks to prevent preterm birth with March of Dimes support 2Health News:Hospital food safety measures reduce risk of contaminated hospital food 2Health News:New approach to prostate cancer screening needed 2Health News:Large-scale study shows power of pre-k 2Health News:Large-scale study shows power of pre-k 3
... MITI ), a biopharmaceutical company developing novel, ... autoimmune diseases, today announced that its President and Chief ... Piper Jaffray 20th Annual Health Care Conference at the ... A simultaneous webcast of the presentation will be ...
... performs the crucial task scientists once thought was the sole ... the production of proteins, the molecules that make cells work ... into intermediary molecules called RNAs, which in turn carry instructions ... the other 98% of the genome? It has been ...
... Barr Pharmaceuticals, Inc. (NYSE: BRL ) today ... a challenge of the patent listed by Anesta in ... and 30mg. , , ... a paragraph IV certification for a generic version of ...
... is a statement of Matthew L. Myers, President, Campaign for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... important action to protect public health by prohibiting tobacco companies ... on an FTC-approved testing method or that they are endorsed ...
... Inc., a leader in the,field of computational immunology, announced today ... Allergy and Infectious Diseases (NIAID),a division of the National Institutes ... will provide EpiVax with $390,000 over two years for the,proposed ... failure of the investigational HIV vaccine tested in the Phase,II ...
... statement by Matthew L. Myers, President of the Campaign for ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... health, a new report released by the nation,s leading cancer ... death rates for all cancers combined are decreasing for both men ...
Cached Medicine News:Health News:Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference 2Health News:Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference 3Health News:Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference 4Health News:Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs 2Health News:Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs 3Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 2Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 3Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 4Health News:FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Give FDA Authority Over Tobacco Products 2Health News:FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Give FDA Authority Over Tobacco Products 3Health News:EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery 2Health News:EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery 3Health News:Report Shows Progress in Fight Against Cancer, but Congress, States Must Step Up Efforts to Reduce Smoking, Lung Cancer 2Health News:Report Shows Progress in Fight Against Cancer, but Congress, States Must Step Up Efforts to Reduce Smoking, Lung Cancer 3Health News:Report Shows Progress in Fight Against Cancer, but Congress, States Must Step Up Efforts to Reduce Smoking, Lung Cancer 4
Our suction kits include a Tri-Flo® suction catheter, a pop-up solution basin and two sturdy, precuffed latex exam gloves in an inner wallet. Infant and pediatric kits (5/6, 8 and 10 Fr) feature ...
Clear plastic sleeve envelopes a plastic suction catheter. Sleeve slides over exudate to reduce potential clinician contact....
Clear plastic sleeve envelopes a plastic suction catheter. Sleeve slides over exudate to reduce potential clinician contact....
Kit includes whistle tip catheter with two eyes and control vent, 2 vinyl gloves, and pop-up solution container in peel- open package....
Medicine Products: